Fusen Pharmaceutical Company Limited (HKG:1652)

Hong Kong · Delayed Price · Currency is HKD

0.8000

0.00 (0.00%)

Aug 26, 2026, 4:08 PM HKT

128.57% (1Y)

Market Cap	591.44M +128.6%
Revenue (ttm)	304.20M -16.2%
Net Income	-13.11M
EPS	-0.02
Shares Out	739.30M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	88,000
Open	0.8000
Previous Close	0.8000
Day's Range	0.8000 - 0.8000
52-Week Range	0.3200 - 1.7500
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 31, 2026

About HKG:1652

Fusen Pharmaceutical Company Limited, an investment holding company, engages in the manufacturing and sale of pharmaceutical products in the People’s Republic of China. The company offers Shuanghuanglian oral solutions and injections; Sanhuang tablet; heat-clearing and detoxicating oral solutions; Flunarizine hydrochloride capsules; Sanhuang tablets; compound ferrous sulfate granules; and other pharmaceutical products. It is also involved in manufacturing and sale of pharmaceutical package materials; research and development of pharmaceutical p... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2003

Employees 1,005

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 1652

Full Company Profile

Financial Performance

In 2025, HKG:1652's revenue was 273.37 million, a decrease of -16.15% compared to the previous year's 326.03 million. Losses were -11.78 million, -93.76% less than in 2024.

Financial numbers in CNY Financial Statements